Tirofiban hydrochloride

Tirofiban Hydrochloride is the hydrochloride salt form of tirofiban, a non-peptide tyrosine derivative with anticoagulant property. Tirofiban antagonizes fibrinogen binding to the platelet cell surface receptor, glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP. The antagonism prevents adenylyl cyclase activation, which mediated via GP IIb/IIIa receptor complex, and results in decreased levels of cAMP and thereby interferes with platelet membrane function and subsequent platelet-platelet interaction, release of platelet granule constituents and prolongation of bleeding time. It is grouped under the following drug class(es): Antiplatelets and Antithrombotic agents. Its therapeutic use is listed as hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Aggrastat and Tirofiban HCl. Its PubChem CID is 64781.

CAS No 142373-60-2
Molecular Formula C22H37ClN2O5S
Molecular Weight 477.1 g/mol
Synonyms (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid;hydrochloride

Frequently Asked Questions